Pegaspargase Bulk API

Pegaspargase is a pegylated form of L-Asparaginase supplied as an active pharmaceutical ingredient for use in injectable oncology formulations. The product is manufactured under controlled cGMP conditions to ensure consistent quality, enzymatic activity and stability suitable for pharmaceutical applications. It belongs to the therapeutic enzyme API category and is intended for parenteral formulations. The material is produced with defined pegylation to extend plasma half-life and reduce immunogenicity compared to native L-Asparaginase. A complete regulatory support package is available, including Drug Master File (DMF), Certificate of Analysis (CoA), stability data and technical documentation. The product is supplied to multiple international markets covering North America, Europe, Asia, the Middle East, Africa and Latin America. For detailed specifications or regulatory documentation, please contact us.